EnginZyme
EnginZyme develops cell-free biomanufacturing technology that uses immobilized enzymes to make chemicals and ingredients through scalable industrial processes.
SEK 75MEquity round
ParticipantSP
Sofinnova Partners
Activity from announced rounds
Activity in this selectionUndisclosed
- Rounds participated in
- 3
- Confirmed lead rounds
- 1 1 roles undisclosed
- New companies
- 3 First participation on record · 0 follow-on
- Funding in participating rounds
- $122.3M 3 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
3 in this selectionHighLife
HighLife Medical develops a transcatheter mitral-valve replacement system designed to treat patients with severe mitral regurgitation without open-heart surgery.
€80MFinancing round
LeadP2 Science
Designs and manufactures renewable specialty ingredients for personal care, fragrance, and performance materials
$23MUndisclosed
Role not disclosed